Show simple item record

dc.contributor.authorPerrotti, Danilo
dc.contributor.authorAgarwal, Anupriya
dc.contributor.authorLucas, Claire
dc.contributor.authorNarla, Goutham
dc.contributor.authorNevanini, Paolo
dc.contributor.authorOdero, Maria D.
dc.contributor.authorRuvolo, Peter P.
dc.contributor.authorVerrills, Nicole M.
dc.date.accessioned2021-03-24T09:23:37Z
dc.date.available2021-03-24T09:23:37Z
dc.date.issued2019-07-17
dc.identifier.citationPerrotti, D., Agarwal, A., Lucas, C. M., Narla, G., Neviani, P., Odero, M. D., ... & Verrills, N. M. (2019). Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”. Science translational medicine, 11(501), eaau0416. https://doi.org/10.1126/scitranslmed.aau0416en_US
dc.identifier.issn1946-6234
dc.identifier.doi10.1126/scitranslmed.aau0416
dc.identifier.urihttp://hdl.handle.net/10034/624385
dc.descriptionThis article is not available on ChesterRep.
dc.description.abstractLB100 does not sensitize CML stem cells to tyrosine kinase inhibitor–induced apoptosis.en_US
dc.language.isoenen_US
dc.publisherAmerican Association for the Advancement of Scienceen_US
dc.relation.urlhttps://www.science.org/doi/10.1126/scitranslmed.aau0416
dc.rightsCC0 1.0 Universal*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.subjectPP2Aen_US
dc.subjectLB100en_US
dc.subjectCMLen_US
dc.subjectLEUKAEMIAen_US
dc.titleComment on PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemiaen_US
dc.typeArticleen_US
dc.identifier.eissn1946-6242en_US
dc.contributor.departmentUniversity of Maryland; Imperial College London; Oregon Health and Science University; University of Chester; University of Michigan; University of Southern California; University of Navarra; MD Anderson Cancer Center; University of Newcastleen_US
dc.identifier.journalScience Translational Medicineen_US
dc.date.accepted2019-05-09
or.grant.openaccessYesen_US
rioxxterms.fundern/aen_US
rioxxterms.identifier.projectn/aen_US
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1126/scitranslmed.aau0416en_US
rioxxterms.licenseref.startdate2221-07-17
dcterms.dateAccepted2019-06-17
rioxxterms.publicationdate2019-07-17
dc.date.deposited2021-03-24en_US
dc.indentifier.issn1946-6234en_US


This item appears in the following Collection(s)

Show simple item record

CC0 1.0 Universal
Except where otherwise noted, this item's license is described as CC0 1.0 Universal